A Nature Communications study reports that calcitonin gene-related peptide (CGRP), a neurotransmitter peptide, contributes to an immunosuppressive tumor microenvironment in medullary thyroid cancer. The findings suggest CGRP signaling may help the cancer evade immune attack and could represent a therapeutic target. The article metrics page itself is only a wrapper, but the underlying paper centers on CGRP biology in cancer immunology.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.